ALEC Trading Analysis - 10/07/2026 11:47 AM — TRU-SENTIMENT

ALEC (Alector Inc. Common Stock) at $1.78. True Sentiment Bullish, delta 40-60 call 65% / put 35%, call $600 vs put $320. RSI 42.3.

TRU-SENTIMENT · DeltaNeutral

ALEC Trading Analysis - 10/07/2026 11:47 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

ALEC (Alector Inc. Common Stock) at $1.78. True Sentiment Bullish, delta 40-60 call 65% / put 35%, call $600 vs put $320. RSI 42.3.

Symbol
ALEC
Price
$1.78
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-10-07 11:47:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Call Dollar Vol $600.00 (65.2%), Put Dollar Vol $320.00 (34.8%), Total $920.00. Sentiment: Bullish. Call contracts 6 vs put 2; 1 call trade, 1 put trade. Filter ratio 3.6% of 56 options analyzed.

Pure directional conviction skews call-heavy despite bearish technicals. Near-term expectations implied: speculative upside bet. Divergence: technicals bearish, sentiment bullish — spread engine flagged "Divergence detected between technical indicators and options sentiment; wait for alignment."

Note: Options flow shows bullish delta-conviction with 65.2% call dollar volume.

Key Statistics: ALEC

$1.78 -0.28%
52-Week Range
$1.09 - $3.40
Market Cap
$199.31M
P/E (TTM)
17.20
PEG Ratio
N/A
Beta
1.64
Next Earnings
N/A
Avg Volume
$2.54M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)17.20
EPS (trailing 12 mo)$-1.09
Market cap$199.31M
Shares outstanding111.7M

Dividend

Dividend yield0.00%

Risk & range

Beta1.64
52-week low$1.09
52-week high$3.40
Historical volatility82.2%

Ownership & trading

Institutional ownership23.2%
Average daily volume6.3M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge context for ALEC (Alector Inc., a clinical-stage biotech focused on neurodegeneration):

  • Phase 2/3 readout for lead Alzheimer's immuno-neurology candidate expected within coming quarters; any delay or mixed data historically moves the stock sharply.
  • Company disclosed ongoing cash-runway management in prior filings; low market cap (~$199M) leaves it sensitive to dilution or partnership headlines.
  • Biotech sector rotation and rate-cut expectations have lifted small-cap names, but ALEC has lagged peers on weak technicals.
  • No confirmed earnings date in provided data; fiscal year end listed as 2025-12-01, suggesting annual filings cycle near.
  • Context: Options flow shows bullish delta-conviction while price sits near 52-week-low zone — possible speculative call positioning ahead of a catalyst not reflected in trend.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for ALEC:

  • Trailing P/E: 17.20; Trailing EPS: -1.09 (negative earnings, P/E derived from skewed base).
  • Market Cap: $199,307,745; Shares Out: 111,657,000; Institutional Ownership: 23.21%.
  • Dividend Yield: 0.00%; Beta: 1.64 (elevated systemic risk).
  • 52-Week High: $3.40; 52-Week Low: $1.09 (current ~$1.79 sits 64% above low).
  • Average Volume: 6,310,000; Historical Volatility: 82.15%.
  • PEG Ratio, Forward P/E, Revenue, Margins, ROE, D/E, FCF: all null — no growth or profitability metrics available.
  • Analyst consensus / target price: null (no coverage data).

Fundamentals show a micro-cap biotech with negative EPS and no disclosed revenue/margin profile. Valuation via trailing P/E is not meaningful given losses. The weak technical picture (price below all SMAs) aligns with absent fundamental strength; only low absolute price and high vol differentiate from a flat bearish read.

Current Market Position

Current price per indicators: $1.79. Daily history shows 2026-10-05 massive volume (87,001,602) with close $1.99 after opening $2.73 — possible offering or news gap-down. 2026-10-06 closed $1.79 (low $1.75, high $2.23, volume 8,744,948). Minute bars 2026-10-06 09:30 open $2.08 fell to $1.98 by 09:50; by 2026-10-07 11:15 price compressed to $1.78 on thinning volume (last bar 6,541).

Support
$1.75
Resistance
$2.23
20-day SMA
$1.97
50-day SMA
$2.03
Bollinger Lower
$1.71

Intraday momentum is flat-to-down with low volume contraction; no recovery above $1.80 sustained.

Technical Analysis

Technical Indicators

Current Price
$1.79
SMA 5
$1.86
SMA 20
$1.97
SMA 50
$2.03
RSI 14
42.33
MACD
-0.07
Signal
-0.06
Hist
-0.01
BB Lower
$1.71
BB Mid
$1.97
BB Upper
$2.23
ATR 14
0.20

Price below SMA 5 ($1.86) < SMA 20 ($1.97) < SMA 50 ($2.03): bearish alignment, no bullish cross. RSI 42.33 reflects weak momentum (sub-50). MACD negative with histogram -0.01 confirms mild bearish pressure. Bollinger mid $1.97, lower $1.71; price near lower third. 30-day range high $2.76, low $1.75; current $1.79 is 2.3% above 30-day low. ATR 0.20 = ~11% daily swing risk.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Call Dollar Vol $600.00 (65.2%), Put Dollar Vol $320.00 (34.8%), Total $920.00. Sentiment: Bullish. Call contracts 6 vs put 2; 1 call trade, 1 put trade. Filter ratio 3.6% of 56 options analyzed.

Pure directional conviction skews call-heavy despite bearish technicals. Near-term expectations implied: speculative upside bet. Divergence: technicals bearish, sentiment bullish — spread engine flagged "Divergence detected between technical indicators and options sentiment; wait for alignment."

Note: Options flow shows bullish delta-conviction with 65.2% call dollar volume.

Key Price Levels (observational only)

30d Low / Daily Low
$1.75
BB Lower
$1.71
SMA 5
$1.86
SMA 20 / BB Mid
$1.97
SMA 50
$2.03
BB Upper / 10-06 High
$2.23

Interactive charts load with JavaScript. This text is the crawlable summary.